Methyl 2-((tert-butoxycarbonyl)amino)-3-(1-methyl-1H-imidazol-5-yl)propanoate

Catalog No. :
ACPJYN327
CAS No. :
1207887-42-0
Molecular Formula :
C13H21N3O4
Molecular Weight :
283.33

IUPAC Name:methyl Na-(tert-butoxycarbonyl)-Np-methylhistidinate

Methyl 2-((tert-butoxycarbonyl)amino)-3-(1-methyl-1H-imidazol-5-yl)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$411.00Login to see priceInquiryInquiry
1g95%$1028.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-((tert-butoxycarbonyl)amino)-3-(1-methyl-1H-imidazol-5-yl)propanoate
IUPAC Namemethyl Na-(tert-butoxycarbonyl)-Np-methylhistidinate
MDL No.MFCD24532498
Molecular FormulaC13H21N3O4
Molecular Weight283.33
SMILESO=C(OC)C(NC(OC(C)(C)C)=O)CC1=CN=CN1C
InChI KeyKEWJAQUOHBEHGW-UHFFFAOYSA-N
SynonymMethyl 2-((Tert-Butoxycarbonyl)Amino)-3-(1-Methyl-1H-Imidazol-5-Yl)Propanoate;Methyl 2-((Tert-Butoxycarbonyl)Amino)-3-(1-Methyl-1H-Imidazol-5-Yl)Propanoate(WXC02443);Histidine, N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-, methyl ester;N-[(1,1-Dimethylethoxy)carbonyl]-3-methylhistidine methyl ester
CAS No.1207887-42-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPJYN327 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPJYN327 route product structure diagram
    ACPJYN3271207887-42-0
Inquiry

2. ACPJYN327 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPJYN327 route product structure diagram
    ACPJYN3271207887-42-0
Inquiry

Comments (0)